Xingyu Mu Selected Research

Kidney Neoplasms (Kidney Cancer)

1/2022

CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xingyu Mu Research Topics

Disease

10	Neoplasms (Cancer) 01/2024 - 01/2016
6	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
4	Carcinogenesis 10/2023 - 01/2016
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2018
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2021
3	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 01/2020
2	Pancreatitis 01/2024 - 01/2023
2	Obesity 01/2024 - 01/2023
2	Plasmacytoma 01/2021 - 01/2020
1	Renal hypouricemia 01/2024
1	Cholecystitis 01/2023
1	Cholelithiasis 01/2023
1	Porokeratosis (Palmoplantar Porokeratosis) 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2022
1	Paranoid Personality Disorder 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2021
2	tirzepatideIBA 01/2024 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Long Noncoding RNAIBA 01/2020 - 01/2020
1	Uric Acid (Urate)IBA 01/2024
1	B7-H1 AntigenIBA 01/2024
1	AntigensIBA 11/2023
1	semaglutideIBA 01/2023
1	AntibodiesIBA 01/2023
1	Insulin Glargine (Lantus)FDA Link 01/2023
1	dulaglutideIBA 01/2023
1	insulin degludecIBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	tofacitinibIBA 01/2023
1	Tuberculin (PPD)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Circular RNAIBA 01/2022
1	ChromatinIBA 01/2022
1	DeoxyuridineIBA 01/2022
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2022
1	Bovine Serum AlbuminIBA 01/2022
1	6-methyladenineIBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	CholesterolIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	AndrogensIBA 01/2020
1	Polyglactin 910IBA 10/2018
1	ArrestinsIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	TensinsIBA 01/2017
1	Ubiquitin-Specific ProteasesIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2019
1	Contraindications 01/2021
1	Intra-Arterial Infusions 01/2021
1	Castration 01/2020
1	Palliative Care (Palliative Therapy) 12/2019
1	Radiotherapy 12/2019
1	Sutures (Suture) 10/2018